Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey DOI Creative Commons
Yongxin Wang,

Chang Fu,

Hengwei Jin

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 17, 2025

Cardiometabolic index (CMI), visceral adiposity (VAI), and lipid accumulation product (LAP) are lipid-related parameters that reflect central obesity, which is closely associated with the development of non-alcoholic fatty liver disease (NAFLD). The aim this study to investigate effectiveness these in diagnosing NAFLD compare their predictive abilities. This population-based extracted datasets from National Health Nutrition Examination Survey (NHANES) 2017-2020. CMI, VAI, LAP were included multivariate logistic model as both continuous categorical variables assess relationship between different NAFLD. To further elucidate connection, we utilized restricted cubic splines conducted subgroup analysis. Additionally, receiver operating characteristics (ROC) curve was employed evaluate for 2,878 adults population, whom 1,263 participants diagnosed When analyzed variables, they showed a positive correlation OR(95%CI) 2.29(1.81,2.89) CMI (per 1-unit), 1.40(1.28,1.52) VAI 1-unit) 1.15(1.11,1.20) 10-units). remains statistically significant when variables. In descending order diagnostic capability NAFLD, AUC values follows: (0.794), (0.752), (0.719). may be important clinical indicators identifying demonstrating best ability among them.

Language: Английский

MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD DOI
Wah‐Kheong Chan, Vincent Wai‐Sun Wong, Leon A. Adams

et al.

Hepatology International, Journal Year: 2024, Volume and Issue: 18(S2), P. 909 - 921

Published: June 24, 2024

Language: Английский

Citations

5

Association of Food Insecurity with the Prevalence and Liver-related Mortality of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) DOI
Zobair M. Younossi, Shira Zelber‐Sagi,

Carina Kuglemas

et al.

Journal of Hepatology, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 1, 2024

Language: Английский

Citations

5

The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia DOI Creative Commons
Saleh A. Alqahtani,

Faisal Abaalkhail,

Saad Alghamdi

et al.

Saudi Journal of Gastroenterology, Journal Year: 2024, Volume and Issue: 30(5), P. 310 - 318

Published: June 28, 2024

Globally, viral hepatitis is decreasing, but nonalcoholic fatty liver disease (NAFLD), now metabolic dysfunction-associated steatotic (MASLD), increasing. We assessed the burden and trends of MASLD in Saudi Arabia.

Language: Английский

Citations

4

Global Burden of Metabolic Dysfunction-Associated Liver Disease, 2010 to 2021☆ DOI Creative Commons
Gong Feng, Giovanni Targher, Christopher D. Byrne

et al.

JHEP Reports, Journal Year: 2024, Volume and Issue: 7(3), P. 101271 - 101271

Published: Nov. 14, 2024

This study used the Global Burden of Disease data (2010-2021) to analyze rates and trends point prevalence, annual incidence, years lived with disability (YLDs) for metabolic dysfunction-associated steatotic liver disease (MASLD) in 204 countries. Total numbers age-standardized per 100,000 population MASLD YLDs were compared across regions countries by age, sex, sociodemographic index (SDI). Smoothing spline models evaluate relationship between burden SDI. Estimates reported uncertainty intervals (UI). Globally, 2021, prevalence 15,018.1 cases (95% UI 13,756.5-16,361.4), incidence 608.5 (598.8-617.7), 0.5 (0.3-0.8) years. was higher men than women (15,731.4 vs. 14,310.6 population). Prevalence peaked at ages 45-49 50-54 women. Kuwait (32,312.2 people; 95% UI: 29,947.1-34,839.0), Egypt (31,668.8 29,272.5-34,224.7), Qatar (31,327.5 29,078.5-33,790.9) had highest 2021. The largest increases estimates from 2010 2021 China (16.9%, 14.7%-18.9%), Sudan (13.3%, 9.8%-16.7%) India (13.2%, 12.0%-14.4%). varied SDI, peaking moderate SDI levels. is a global health concern, Kuwait, Egypt, Qatar. Raising awareness about risk factors prevention essential every country, especially China, India, where are rapidly increasing. research provides comprehensive analysis MASLD, highlighting its rising particularly varying indices. findings significant both clinicians policymakers, as they offer critical insights into regional disparities burden, which can inform targeted intervention strategies. However, study's reliance on modeling available suggests cautious interpretation, further needed validate these clinical real-world settings.

Language: Английский

Citations

4

Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey DOI Creative Commons
Yongxin Wang,

Chang Fu,

Hengwei Jin

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 15

Published: Jan. 17, 2025

Cardiometabolic index (CMI), visceral adiposity (VAI), and lipid accumulation product (LAP) are lipid-related parameters that reflect central obesity, which is closely associated with the development of non-alcoholic fatty liver disease (NAFLD). The aim this study to investigate effectiveness these in diagnosing NAFLD compare their predictive abilities. This population-based extracted datasets from National Health Nutrition Examination Survey (NHANES) 2017-2020. CMI, VAI, LAP were included multivariate logistic model as both continuous categorical variables assess relationship between different NAFLD. To further elucidate connection, we utilized restricted cubic splines conducted subgroup analysis. Additionally, receiver operating characteristics (ROC) curve was employed evaluate for 2,878 adults population, whom 1,263 participants diagnosed When analyzed variables, they showed a positive correlation OR(95%CI) 2.29(1.81,2.89) CMI (per 1-unit), 1.40(1.28,1.52) VAI 1-unit) 1.15(1.11,1.20) 10-units). remains statistically significant when variables. In descending order diagnostic capability NAFLD, AUC values follows: (0.794), (0.752), (0.719). may be important clinical indicators identifying demonstrating best ability among them.

Language: Английский

Citations

0